Dashboard
Manage Tickers

MYGN


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

key-takeaways-from-myriad-genetics-analyst-ratings
Key Takeaways From Myriad Genetics Analyst...
06/27/2024 14:00:36

scotiabank-initiates-coverage-on-myriad-genetics-with-sector-outperform-rating-announces-price-target-of-29
Scotiabank Initiates Coverage On Myriad Ge...
06/27/2024 12:59:25

Scotiabank analyst Sung Ji Nam initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Sector Outperform rating and annou...

myriad-genetics-collaborates-with-gsk-to-improve-access-on-homologous-recombination-deficiency-testing-in-9-countries
Myriad Genetics Collaborates With GSK To I...
06/11/2024 12:06:59

myriad-genetics-launches-new-universal-plus-panel-for-its-foresight-carrier-screen
Myriad Genetics Launches New Universal Plu...
06/04/2024 13:01:10

Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the addition of a new ...

myriad-genetics-patient-outcomes-study-validating-riskscore-as-clinical-breast-cancer-risk-assessment-tool-published-in-medical-genetics-and-genomics
Myriad Genetics Patient-Outcomes Study Val...
06/03/2024 20:13:52

jefferies-assumes-myriad-genetics-at-underperform-lowers-price-target-of-20
Jefferies Assumes Myriad Genetics at Under...
06/03/2024 13:11:27

Jefferies analyst Tycho Peterson assumes Myriad Genetics (NASDAQ:MYGN) with a Underperform rating and lowers Price Target of...

Core News & Articles
QIAGEN And Myriad Genetics To Develop Glob...
05/30/2024 20:30:33

myriad-genetics-study-published-in-jco-precision-oncology-shows-cos-prolaris-test-can-predict-benefit-of-hormone-therapy-treatment-in-men-with-localized-prostate-cancer
Myriad Genetics Study Published In JCO Pre...
05/16/2024 20:30:28

Myriad's Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiat...

piper-sandler-maintains-neutral-on-myriad-genetics-raises-price-target-to-28
Piper Sandler Maintains Neutral on Myriad ...
05/13/2024 12:55:45

Piper Sandler analyst John Peterson maintains Myriad Genetics (NASDAQ:MYGN) with a Neutral and raises the price target from ...

leerink-partners-upgrades-myriad-genetics-to-outperform-raises-price-target-to-35
Leerink Partners Upgrades Myriad Genetics ...
05/08/2024 17:54:35

Leerink Partners analyst Puneet Souda upgrades Myriad Genetics (NASDAQ:MYGN) from Market Perform to Outperform and raises th...

why-upstart-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Upstart Shares Are Trading Lower By Ar...
05/08/2024 17:38:56

louisiana-pacific-posts-upbeat-results-joins-cricut-elanco-animal-american-public-education-and-other-big-stocks-moving-higher-on-wednesday
Louisiana-Pacific Posts Upbeat Results, Jo...
05/08/2024 15:11:22

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 12:06:34

myriad-genetics-sees-fy24-adj-eps-000-005-vs-002-est-revenue-820m-840m-vs-826582m-est
Myriad Genetics Sees FY24 Adj. EPS $0.00-$...
05/07/2024 21:41:41

myriad-genetics-q1-2024-adj-eps-001-beats-010-estimate-sales-202200m-beat-193506m-estimate
Myriad Genetics Q1 2024 Adj EPS $(0.01) Be...
05/07/2024 21:22:20

Myriad Genetics (NASDAQ:MYGN) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.1...

myriad-genetics-announces-reorganization-of-european-operations-and-sale-of-endopredict-business-no-financial-terms-disclosed--deal-is-subject-to-customary-closing-conditions-expects-the-transaction-to-close-in-q2-or-q3-of-2024
Myriad Genetics Announces Reorganization O...
05/07/2024 13:06:57

Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the reorganization of...

new-myriad-genetics-published-study-demonstrating-ppv-for-221222-microdeletion-screening-using-prequel-prenatal-screen
New Myriad Genetics Published Study Demons...
04/16/2024 13:18:59

myriad-genetics-research-shows-reduction-in-hospitalizations-for-patients-with-depression-after-genesight-testing
Myriad Genetics Research Shows Reduction I...
04/09/2024 12:05:05

reported-earlier-myriad-genetics-granted-foundational-patent-for-molecular-residual-disease-mrd-with-early-priority-date
Reported Earlier, Myriad Genetics Granted ...
03/22/2024 07:14:37

myriad-genetics-says-us-patent-and-trademark-office-has-granted-patent-that-covers-use-of-push-button-blood-collection-devices-for-pcr-based-fetal-sex-determination
Myriad Genetics Says US Patent And Tradema...
03/20/2024 20:08:13

U.S. Patent No. 11,932,907, titled Fetal Sex Determination Using Capillary Blood From Upper Arm, provides protection for Myriad...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)